DOCSLIB.ORG

Diabetic Cardiomyopathy: the Case for a Role of Fructose in Disease Etiology

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Diabetic Cardiomyopathy: the Case for a Role of Fructose in Disease Etiology Diabetes Volume 65, December 2016 3521 Lea M.D. Delbridge,1 Vicky L. Benson,2 Rebecca H. Ritchie,3 and Kimberley M. Mellor1,2,4 Diabetic Cardiomyopathy: The Case for a Role of Fructose in Disease Etiology Diabetes 2016;65:3521–3528 | DOI: 10.2337/db16-0682 A link between excess dietary sugar and cardiac disease as a specific myocardial pathology, the occurrence of which is clearly evident and has been largely attributed to is independent of coronary and hypertensive disease. Di- systemic metabolic dysregulation. Now a new paradigm abetic cardiomyopathy is generally characterized by early is emerging, and a compelling case can be made that signs of diastolic dysfunction, which precede progression to fructose-associated heart injury may be attributed to the systolic failure (6,7). direct actions of fructose on cardiomyocytes. Plasma While the relationship between excess fructose exposure and cardiac fructose levels are elevated in patients with and cardiac disease development has been identified, the PERSPECTIVES IN DIABETES diabetes, and evidence suggests that some unique underlying mechanisms are as yet only partially under- fi properties of fructose (vs. glucose) have speci c car- stood. Aspects of diabetic cardiomyopathy that may be diomyocyte consequences. Investigations to date have attributed specifically to high fructose intake or to selective demonstrated that cardiomyocytes have the capacity to myocardial fructose metabolic dysregulation have not been transport and utilize fructose and express all of the determined. Whether cardiac vulnerability associated with necessary proteins for fructose metabolism. When di- etary fructose intake is elevated and myocardial glucose fructose exposure produces an injury response beyond uptake compromised by insulin resistance, increased effects that may be attributed to general overnutrition or fi cardiomyocyte fructose flux represents a hazard in- to overall excess consumption of re ned sugar (either volving unregulated glycolysis and oxidative stress. The glucose or fructose) in different diabetic settings is also high reactivity of fructose supports the contention that not yet known (8,9). fructose accelerates subcellular hexose sugar-related In this Perspective, these questions relating to fructose, protein modifications, such as O-GlcNAcylation and ad- diabetes, and the heart are examined, and the case for a role vanced glycation end product formation. Exciting recent of fructose in diabetic cardiomyopathy disease etiology is discoveries link heart failure to induction of the specific explored. Evidence to support the proposition that fructose high-affinity fructose-metabolizing enzyme, fructokinase, is a distinctive cardiopathogenic agent in diabetes and in an experimental setting. In this Perspective, we review states of metabolic disturbance is considered. Findings from key recent findings to synthesize a novel view of fructose a diverse range of investigative approaches are reviewed to as a cardiopathogenic agent in diabetes and to identify synthesize a novel view of fructose (of exogenous and en- important knowledge gaps for urgent research focus. dogenous origin) as a perpetrator of cardiac damage. New insights into fructose-induced myocardial functional and signaling dysregulation are discussed, and knowledge gaps Links between excess fructose consumption, diabetes in- for priority research focus are identified. cidence, and cardiovascular disease risk have been clearly demonstrated (1–4). The systemic effects of high fructose DIETARY FRUCTOSE AND CARDIOMYOPATHY intake have been well described experimentally and include Dietary Fructose Increases Cardiovascular Risk hyperglycemia, dyslipidemia, atherosclerosis, and in some The dramatic rise in the prevalence of diabetes has oc- cases hypertension (5). Diabetic cardiomyopathy is recognized curred in parallel with an escalation in dietary sugar 1Department of Physiology, University of Melbourne, Victoria, Australia Received 31 May 2016 and accepted 9 September 2016. 2 Department of Physiology, University of Auckland, Auckland, New Zealand © 2016 by the American Diabetes Association. Readers may use this article as 3 Heart Failure Pharmacology, Baker IDI Heart and Diabetes Institute, Victoria, long as the work is properly cited, the use is educational and not for profit, and the Australia work is not altered. More information is available at http://www.diabetesjournals 4 Auckland Bioengineering Institute, University of Auckland, Auckland, New Zealand .org/content/license. Corresponding author: Lea M.D. Delbridge, [email protected]. 3522 Fructose-Induced Cardiac Pathology Diabetes Volume 65, December 2016 consumption. In “westernized” cultures, the use of added results in metabolic dysregulation and cell death vulnera- sweeteners containing fructose(sucroseandhigh-fructose bility. Rodents fed a high-fructose diet for several months corn syrup) has increased by approximately 25% over the display significant decreases in the levels of phosphory- past three decades (10). Meta-analyses of cohort studies lated Akt (Ser473) and the downstream signaling inter- have determined that high intake of fructose-sweetened mediate S6 (Ser235/236) with decreased PI3K activity beverages is associated with a 26% greater risk of cardio- and phosphorylation of Akt (19,20). Interestingly, insulin metabolic pathology (2). Experimental studies of hepatic growth factor 1 (IGF1) and IGF1 receptor expression are fructose metabolism have shown that genetically modified both decreased in this setting, suggesting involvement rodents unable to metabolize fructose (fructokinase knock- from the IGF1 signaling pathway in addition to insulin- out) are protected from high-carbohydrate–induced meta- receptor–mediated effects (20). Fructose feeding also di- bolic syndrome, supporting the contention that fructose is minishes cardiac glucose uptake (21). Thus despite elevated the toxic component of the sugar complex (11,12). Although extracellular glucose levels, intracellular glucose availability increased cardiovascular disease risk may be partially attrib- is reduced, which is associated with upregulation of cardiac uted to fructose-induced dyslipidemia, atherosclerosis, hy- lipid derivatives and transporters (22), indicative of a sub- pertension, obesity, or insulin resistance/diabetes/metabolic strate shift from glucose to fatty acids for energy supply. syndrome (13,14), it is increasingly apparent that fructose- Energetic disturbances may manifest as triggers for oxi- specific cardiac factors are important. Recent studies have dative stress in response to excess dietary fructose (23). demonstrated that dietary fructose is not necessarily asso- Mitochondrial uncoupling is evident in hearts of fructose- ciated with changes in blood pressure (15), and the relation- fed rodents (24) and is associated with elevated myocar- ship between high sugar intake and increased risk for both dial production of reactive oxygen species (25). Impaired type 2 diabetes and cardiovascular disease is independent of glucose uptake and utilization has also been linked to an BMI (2,16), which indicates that calorie intake and adipose inability to respond to an ischemic challenge. In contrast deposition are not the underlying etiology. to controls, fructose-fed animals do not increase cardiomyo- Emerging evidence suggests that cardiac complications cyte GLUT4 translocation and glycolytic flux in response to in patients with diabetes (and their attenuation) are not ischemia (26), a response deficit that may underlie chronic alwayslinkedtothedegreeofbloodglucosecontrol.Meta- ischemic vulnerability in diabetic settings. Interestingly, two analyses of large randomized controlled clinical trials report studies have reported smaller infarct size in isolated hearts that drugs used to lower blood glucose levels in patients with from fructose-fed rats (27,28), suggesting that metabolic diabetes may exacerbate heart failure symptoms and in- adaptation involving modified routes of cardiomyocyte crease the risk of heart failure (17,18). While some glucose- hexose sugar uptake may actually have a role in acute lowering agents (metformin, emphafliglozin) have been cardioprotection. shown to be cardioprotective in patients with diabetes, others do not improve cardiac dysfunction and can lead Dietary Fructose–Induced Cardiac Cell Loss to increased heart failure risk (e.g., peroxisome proliferator– and Dysfunction activated receptor agonists, dipeptidyl peptidase 4 inhibitors, Downregulation of the cardiomyocyte PI3K/Akt “cell sur- thiazolidinediones). Thus negative cardiac impacts in di- vival’’ pathway can promote cell death signaling as inhibi- abetes involve mechanisms not necessarily responsive to tion of programmed cell death pathways via the PI3K/Akt normalization of circulating glucose levels. As cardiac tis- axis is relieved. Fructose feeding in rodents is associated sue is both insulin sensitive and glycolysis dependent, with low-level constitutive loss of cardiomyocytes coupled increased cardiac vulnerability to fructose in the context with increased collagen deposition, producing a progressive of metabolic dysregulation is plausible (5) and supported fibrotic replacement of viable myocardium (19). In feeding by an accumulating experimental evidence base. As empha- interventions where the metabolic disturbance is moderate, sized in important recent commentaries (4,12), although of apoptotic signaling pathways are not found to be activated caloric equivalence, fructose and glucose are very different but
Load more

Recommended publications
  • Glycation Marker Glucosepane Increases with the Progression Of
    Legrand et al. Arthritis Research & Therapy (2018) 20:131 https://doi.org/10.1186/s13075-018-1636-6 RESEARCHARTICLE Open Access Glycation marker glucosepane increases with the progression of osteoarthritis and correlates with morphological and functional changes of cartilage in vivo Catherine Legrand1†, Usman Ahmed2,3†, Attia Anwar2, Kashif Rajpoot4, Sabah Pasha2, Cécile Lambert1, Rose K. Davidson5, Ian M. Clark5, Paul J. Thornalley2,3, Yves Henrotin1,6 and Naila Rabbani2,3* Abstract Background: Changes of serum concentrations of glycated, oxidized, and nitrated amino acids and hydroxyproline and anticyclic citrullinated peptide antibody status combined by machine learning techniques in algorithms have recently been found to provide improved diagnosis and typing of early-stage arthritis of the knee, including osteoarthritis (OA), in patients. The association of glycated, oxidized, and nitrated amino acids released from the joint with development and progression of knee OA is unknown. We studied this in an OA animal model as well as interleukin-1β-activated human chondrocytes in vitro and translated key findings to patients with OA. Methods: Sixty male 3-week-old Dunkin-Hartley guinea pigs werestudied.Separategroupsof12animalswerekilledat age 4, 12, 20, 28 and 36 weeks, and histological severity of knee OA was evaluated, and cartilage rheological properties were assessed. Human chondrocytes cultured in multilayers were treated for 10 days with interleukin-1β. Human patients with early and advanced OA and healthy controls were recruited, blood samples were collected, and serum or plasma was prepared. Serum, plasma, and culture medium were analyzed for glycated, oxidized, and nitrated amino acids. Results: Severity of OA increased progressively in guinea pigs with age.
    [Show full text]
  • Protein Carbamylation Is a Hallmark of Aging SEE COMMENTARY
    Protein carbamylation is a hallmark of aging SEE COMMENTARY Laëtitia Gorissea,b, Christine Pietrementa,c, Vincent Vuibleta,d,e, Christian E. H. Schmelzerf, Martin Köhlerf, Laurent Ducaa, Laurent Debellea, Paul Fornèsg, Stéphane Jaissona,b,h, and Philippe Gillerya,b,h,1 aUniversity of Reims Champagne-Ardenne, Extracellular Matrix and Cell Dynamics Unit CNRS UMR 7369, Reims 51100, France; bFaculty of Medicine, Laboratory of Medical Biochemistry and Molecular Biology, Reims 51100, France; cDepartment of Pediatrics (Nephrology Unit), American Memorial Hospital, University Hospital, Reims 51100, France; dDepartment of Nephrology and Transplantation, University Hospital, Reims 51100, France; eLaboratory of Biopathology, University Hospital, Reims 51100, France; fInstitute of Pharmacy, Faculty of Natural Sciences I, Martin Luther University Halle-Wittenberg, Halle 24819, Germany; gDepartment of Pathology (Forensic Institute), University Hospital, Reims 51100, France; and hLaboratory of Pediatric Biology and Research, Maison Blanche Hospital, University Hospital, Reims 51100, France Edited by Bruce S. McEwen, The Rockefeller University, New York, NY, and approved November 23, 2015 (received for review August 31, 2015) Aging is a progressive process determined by genetic and acquired cartilage, arterial wall, or brain, and shown to be correlated to the factors. Among the latter are the chemical reactions referred to as risk of adverse aging-related outcomes (5–10). Because AGE nonenzymatic posttranslational modifications (NEPTMs), such as formation
    [Show full text]
  • Advanced Glycation End Products
    ition & F tr oo u d N f S o c l i e a n n c r e u s o J Journal of Nutrition & Food Sciences Abate G, et al., J Nutr Food Sci 2015, 5:6 ISSN: 2155-9600 DOI: 10.4172/2155-9600.1000440 Review Artice Open Access Advanced Glycation End Products (AGEs) in Food: Focusing on Mediterranean Pasta Abate G1, Delbarba A2, Marziano M1, Memo M1 and Uberti D1,2* 1Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy. 2Diadem Ltd, Spin Off of Brescia University, Brescia, Italy. *Corresponding author: Uberti D, Department of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy, Tel: +39-0303717509; E-mail: [email protected] Rec Date: Nov 16, 2015; Acc Date: Nov 26, 2015; Pub Date: Nov 30, 2015 Copyright: © 2015 Abate G, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Abstract Advanced glycation end products, also known as glycotoxins, are a diverse group of highly oxidant compounds with pathogenic significance in aged-chronic disease, including diabetes, cardiovascular disease and neurodegenerative disease. They are produced physiologically in the body when reducing sugar binds to a free amino acid group of macromolecules. Thus conditions such as hyperglycemia and/or oxidative stress can favor AGE product formation, contributing to ageing processes and the exacerbation of pathological states. Beside endogenous AGEs, dietary AGE intake contributes significantly to the body AGE pool.
    [Show full text]
  • Skin Advanced Glycation Endproducts (Ages) Glucosepane And
    Page 1 of 47 Diabetes Skin Advanced Glycation Endproducts (AGEs) Glucosepane and Methylglyoxal Hydroimidazolone are Independently Associated with Long- term Microvascular Complication Progression of Type I diabetes Saul Genuth1*, Wanjie Sun2, Patricia Cleary2, Xiaoyu Gao2, David R Sell3, John Lachin2, the DCCT/EDIC Research Group, Vincent M. Monnier3,4* Short Title: Collagen AGEs and Microvascular Complications Departments: From the 1Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio; the 2Biostatistics Center, George Washington University, Rockville, Maryland; the 3Departments of Pathology and 4Biochemistry, and Case Western Reserve University School of Medicine, Cleveland, Ohio. *Co-corresponding authors: Vincent Monnier MD, 216-368-6613 [phone]; 216-368-1357[fax], email: [email protected], and Saul Genuth MD, email: [email protected]; 216-368-5032[phone]; 216-844-8900[fax] 1 Diabetes Publish Ahead of Print, published online September 3, 2014 Diabetes Page 2 of 47 Abbreviations: AER, albumin excretion rate; AGE, advanced glycation end product; CML, Nε- (carboxymethyl)-lysine; DCCT, Diabetes Control and Complications Trial; EDIC, Epidemiology of Diabetes Interventions and Complications; GSPNE, glucosepane; CEL, carboxyethyl-lysine; G-H1, glyoxal hydroimidazolone; MG-H1, methylglyoxal hydroimidazolone. EDTRS, Early Treatment of Diabetic Retinopathy Scale; LRT, likelihood ratio test. 2 Page 3 of 47 Diabetes ABSTRACT Six skin collagen AGEs originally measured near Diabetes Control and Complications Trial (DCCT) closeout in 1993 may contribute to the “metabolic memory” phenomenon reported in the follow-up EDIC complications study. We now investigated whether addition of 4 originally unavailable AGEs, i.e. glucosepane (GSPNE), hydroimidazolones of methylglyoxal (MG-H1) and glyoxal (G-H1), and carboxyethyl-lysine (CEL), improves associations with incident retinopathy , nephropathy , and neuropathy events during 13-17 years post DCCT.
    [Show full text]
  • Attenuation of Glucose-Induced Myoglobin Glycation and the Formation of Advanced Glycation End Products (Ages) by (R)-Α-Lipoic Acid in Vitro
    biomolecules Article Attenuation of Glucose-Induced Myoglobin Glycation and the Formation of Advanced Glycation End Products (AGEs) by (R)-α-Lipoic Acid In Vitro Hardik Ghelani 1,2, Valentina Razmovski-Naumovski 1,2,3, Rajeswara Rao Pragada 4 and Srinivas Nammi 1,2,* ID 1 School of Science and Health, Western Sydney University, Sydney, NSW 2751, Australia; [email protected] (H.G.); [email protected] (V.R.-N.) 2 National Institute of Complementary Medicine (NICM), Western Sydney University, Sydney, NSW 2751, Australia 3 South Western Sydney Clinical School, School of Medicine, University of New South Wales, Sydney, NSW 2052, Australia 4 Department of Pharmacology, College of Pharmaceutical Sciences, Andhra University, Visakhapatnam 530003, Andhra Pradesh, India; [email protected] * Correspondence: [email protected]; Tel.: +61-2-4620-3038; Fax: +61-2-4620-3025 Received: 1 December 2017; Accepted: 1 February 2018; Published: 8 February 2018 Abstract: High-carbohydrate containing diets have become a precursor to glucose-mediated protein glycation which has been linked to an increase in diabetic and cardiovascular complications. The aim of the present study was to evaluate the protective effect of (R)-α-lipoic acid (ALA) against glucose-induced myoglobin glycation and the formation of advanced glycation end products (AGEs) in vitro. Methods: The effect of ALA on myoglobin glycation was determined via the formation of AGEs fluorescence intensity, iron released from the heme moiety of myoglobin and the level of fructosamine. The extent of glycation-induced myoglobin oxidation was measured via the levels of protein carbonyl and thiol. Results: The results showed that the co-incubation of ALA (1, 2 and 4 mM) with myoglobin (1 mg/mL) and glucose (1 M) significantly decreased the levels of fructosamine, which is directly associated with the decrease in the formation of AGEs.
    [Show full text]
  • Protein Glycation in Plants—An Under-Researched Field with Much Still to Discover
    International Journal of Molecular Sciences Review Protein Glycation in Plants—An Under-Researched Field with Much Still to Discover Naila Rabbani 1,*, Maryam Al-Motawa 2,3 and Paul J. Thornalley 2,3,* 1 Department of Basic Medical Science, College of Medicine, QU Health, Qatar University, Doha P.O. Box 2713, Qatar 2 Diabetes Research Center, Qatar Biomedical Research Institute, Hamad Bin Khalifa University, Qatar Foundation, Doha P.O. Box 34110, Qatar; [email protected] 3 College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation, Doha P.O. Box 34110, Qatar * Correspondence: [email protected] (N.R.); [email protected] (P.J.T.); Tel.: +974-7479-5649 (N.R.); +974-7090-1635 (P.J.T.) Received: 9 April 2020; Accepted: 28 May 2020; Published: 30 May 2020 Abstract: Recent research has identified glycation as a non-enzymatic post-translational modification of proteins in plants with a potential contributory role to the functional impairment of the plant proteome. Reducing sugars with a free aldehyde or ketone group such as glucose, fructose and galactose react with the N-terminal and lysine side chain amino groups of proteins. A common early-stage glycation adduct formed from glucose is N"-fructosyl-lysine (FL). Saccharide-derived reactive dicarbonyls are arginine residue-directed glycating agents, forming advanced glycation endproducts (AGEs). A dominant dicarbonyl is methylglyoxal—formed mainly by the trace-level degradation of triosephosphates, including through the Calvin cycle of photosynthesis. Methylglyoxal forms the major quantitative AGE, hydroimidazolone MG-H1. Glucose and methylglyoxal concentrations in plants change with the developmental stage, senescence, light and dark cycles and also likely biotic and abiotic stresses.
    [Show full text]
  • Protection Against Glycation and Similar Post-Translational Modifications of Proteins ⁎ John J
    Biochimica et Biophysica Acta 1764 (2006) 1436–1446 www.elsevier.com/locate/bbapap Review Protection against glycation and similar post-translational modifications of proteins ⁎ John J. Harding , Elena Ganea 1 Nuffield Laboratory of Ophthalmology, University of Oxford, Walton Street, Oxford, OX2 6AW, Great Britain Received 23 April 2006; received in revised form 29 July 2006; accepted 2 August 2006 Available online 5 August 2006 Abstract Glycation and other non-enzymic post-translational modifications of proteins have been implicated in the complications of diabetes and other conditions. In recent years there has been extensive progress in the search for ways to prevent the modifications and prevent the consequences of the modifications. These areas are covered in this review together with newer ideas on possibilities of reversing the chemical modifications. © 2006 Elsevier B.V. All rights reserved. Keywords: AGE; Aminoguanidine; Aspirin; Conformation; Glycation; Post-translational modification 1. Introduction Glycation increases with age as do sugar concentrations, impairing protein function. In diabetes, sugar concentrations, the Proteins exist in an environment surrounded by reactive small extent of glycation and the degree of damage increase in parallel. molecules and it is inevitable that these molecules will react with Glycation may be the main cause of diabetic complications. the proteins even without the benefit of enzymic catalysis. The small molecules include metabolites, especially sugars; and 2.1. The glycation reactions xenobiotics,
    [Show full text]
  • Glycation of Lysozyme Wisam Talib Joudah [email protected]
    Marshall University Marshall Digital Scholar Theses, Dissertations and Capstones 2015 Glycation of Lysozyme Wisam Talib Joudah [email protected] Follow this and additional works at: http://mds.marshall.edu/etd Part of the Biochemistry Commons, and the Chemistry Commons Recommended Citation Joudah, Wisam Talib, "Glycation of Lysozyme" (2015). Theses, Dissertations and Capstones. Paper 950. This Thesis is brought to you for free and open access by Marshall Digital Scholar. It has been accepted for inclusion in Theses, Dissertations and Capstones by an authorized administrator of Marshall Digital Scholar. For more information, please contact [email protected]. GLYCATION OF LYSOZYME A thesis submitted to the Graduate College of Marshall University In partial fulfillment of the requirements for the degree of Master of Science in Chemistry by Wisam Talib Joudah Approved by Dr. Leslie Frost, Committee Chairperson Dr. Derrick Kolling Dr. Bin Wang Marshall University August 2015 DEDICATION I dedicate my thesis work to my family and friends, especially to my beloved mother, who taught me that even the largest task can be accomplished if it is done one step at a time, whose prayers and words of encouragement got me to this point, and to my deceased father, Mr. Talib, who had dreamt to live to see this moment. Likewise, I want to dedicate this work and to my siblings who have been a constant encouragement and support throughout the duration of my study. This work is also dedicated to my brother, Marwan, for his moral support that helped me to overcome all the difficulties that I have encountered during my study.
    [Show full text]
  • Proteolysis of the Receptor for Advanced Glycation End Products by Matrix Metalloproteinases
    Proteolysis of the Receptor for Advanced Glycation End Products by Matrix Metalloproteinases Dissertation Zur Erlangung des Grades Doktor der Naturwissenschaften Am Fachbereich Biologie Der Johannes Gutenberg-Universität Mainz Ling Zhang geb. am 22-10-1972 in Wuhan, China Mainz 2006 i Table of Content Table of Contents Table of Contents ...................................................................................................................................ii 1. Introduction ....................................................................................................................................... 1 1.1 The A β peptide ................................................................................................................................. 1 1.1.1 A β peptide production and its pathologic role in Alzheimer’s disease (AD) ........................... 1 1.1.2 A β peptide clearance from the brain .......................................................................................... 2 1.2 RAGE (receptor for advanced glycation end products) .............................................................. 4 1.2.1 Structure ....................................................................................................................................... 4 1.2.2 Expression patterns ...................................................................................................................... 5 1.2.3 Extracellular ligands and their pathophysiolologic functions .................................................
    [Show full text]
  • Protein Glycation, Diabetes, and Aging
    Protein Glycation, Diabetes, and Aging PETER ULRICH AND ANTHONY CERAMI The Kenneth S. Warren Laboratories, 765 Old Saw Mill River Road, Tarrytown, New York 10591 ABSTRACT Biological amines react with reducing sugars to form a complex family of rearranged and dehydrated covalent adducts that are often yellow-brown and/or fluorescent and include many cross- linked structures. Food chemists have long studied this process as a source of flavor, color, and texture changes in cooked, processed, and stored foods. During the 1970s and 198Os, it was realized that this process, called the Maillard reaction or advanced glycation, also occurs slowly in vivo. Advanced glycation endproducts (AGES) that form are implicated, causing the complications of diabetes and aging, primarily via adventitious and crosslinking of proteins. Long-lived proteins such as structural collagen and lens crystallins particularly are implicated as pathogenic targets of AGE processes, AGE formation in vascular wall collagen appears to be an especially deleterious event, causing crosslinking of collagen molecules to each other and to circulating proteins. This leads to plaque formation, basement membrane thickening, and loss of vascular elasticity. The chemistry of these later-stage, glycation-derrved crosslinks is still incompletely understood but, based on the hypothesis that AGE formation involves reactive carbonyl groups, the authors introduced the carbonyl reagent ami- noguanidine hydrochloride as an inhibitor of AGE formation in vivo in the mid 1980s. Subsequent studies by many researchers have shown the effectiveness of aminoguanidine in slowing or preventing a wide range of complications of diabetes and aging in animals and, recently, in humans. Since, the authors have developed a new class of agents, exemplified by 4,5-dimethyl-3-phenacylthiazolium chloride (DPTC), which can chemically break already-formed AGE protein-protein crosslinks.
    [Show full text]
  • Diet, Skin Aging, and Glycation Zoe Diana Draelos, MD
    CosmetiC Consultation Diet, Skin Aging, and Glycation Zoe Diana Draelos, MD or years, dermatologic researchers have been can occur both outside (exogenous) and inside (endog- postulating the effects of diet on the skin. Many enous) the body, both inducing detrimental effects. Ffamiliar sayings regarding diet and health abound, such as “you are what you eat,” “eat your way young,” What is exogenous glycation and how does it and “junk food in and bad health out.” As a whole, phy- affect the body? sicians recognize that healthy skin, hair, and nails are an Exogenous glycation occurs when foods containing gly- indication of general good health, and the first signs of cated proteins are consumed. At temperatures over 248°F, illness can be visualized in the eyes and the facial skin. sugars readily bind to proteins to form advanced AGEs. When an ill child is examined, the first comment may When it occurs in foods, this process is known as the be that the child looks sick. What does it mean to look Maillard reaction. Glycated proteins that commonly are sick? In part, it means the patient’s skin does not look consumed in the human diet manifest as grill marks on good, which begs the question, how does a patient’s grilled meat, brown crust on bread, the brown color of health relate to attractive-looking skin? Furthermore, malted barley, and the browning of toasted bread. The can a certain diet help patients achieve more beautiful Maillard reaction results when the reactive carbonyl group skin and a younger appearance?COS DERMof the sugar reacts with the nucleophilic amino group of Diet supplements claiming to improve skin health the amino acid to create molecules that impart flavor and abound.
    [Show full text]
  • Development of a Novel Ssdna Sequence for a Glycated Human Serum Albumin and Construction of a Simple Aptasensor System Based on Reduced Graphene Oxide (Rgo)
    biosensors Article Development of a Novel ssDNA Sequence for a Glycated Human Serum Albumin and Construction of a Simple Aptasensor System Based on Reduced Graphene Oxide (rGO) 1, 1, 1 2 2 A-Ru Kim y, Yeongmi Choi y, Sang-Heon Kim , Hyun-Seok Moon , Jae-Ho Ko and Moon-Young Yoon 1,* 1 Department of Chemistry and Research Institute of Natural Sciences, Hanyang University, Seoul 04763, Korea; [email protected] (A.-R.K.); [email protected] (Y.C.); [email protected] (S.-H.K.) 2 Sungsan Eng Co.ltd., Gumi 39377, Korea; [email protected] (H.-S.M.); [email protected] (J.-H.K.) * Correspondence: [email protected]; Tel.: +82-2-2220-0946 These authors contributed equally to this work. y Received: 21 September 2020; Accepted: 12 October 2020; Published: 14 October 2020 Abstract: Diabetes is one of the top 10 global causes of death. About one in 11 global adults have diabetes. As the disease progresses, the mortality rate increases, and complications can develop. Thus, early detection and effective management of diabetes are especially important. Herein, we present a novel glycated human serum albumin (GHSA) aptamer, i.e., GABAS-01, which has high affinity and specificity. The aptamer was selected by reduced graphene oxide-based systematic evolution of ligands by exponential enrichement (rGO-based SELEX) against GHSA. After five rounds of selection through gradually harsher conditions, GABAS-01 with high affinity and specificity for the target was obtained. GABAS-01 was labeled by FAM at the 50-end and characterized by measuring the recovery of a fluorescence signal that is the result of fluorescence quenching effect of rGO.
    [Show full text]